德国卓越医学中心在 COVID-19 大流行的头 2 年中的癌症护理情况。
Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic.
机构信息
Division of Clinical Epidemiology and Aging Research (C070), Unit of Cancer Survivorship (C071), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT), Heidelberg, Germany.
出版信息
J Cancer Res Clin Oncol. 2023 Feb;149(2):913-919. doi: 10.1007/s00432-022-04407-1. Epub 2022 Oct 14.
PURPOSE
An increasing number of international studies demonstrate serious negative effects of the COVID-19 pandemic on the timely diagnosis of cancer and on cancer treatment. Our study aimed to quantitatively and qualitatively evaluate the capacities of German Comprehensive Cancer Centers (CCCs) in different areas of complex oncology care during the first 2 years of the COVID-19 pandemic.
METHODS
Prospective panel survey over 23 rounds among 18 CCCs in Germany between March 2020 and June 2022.
RESULTS
The COVID-19 pandemic substantially affected the oncological care system in Germany during the first 2 years. Persistent limitations of care in CCCs primarily affected follow-up (- 21%) and psycho-oncologic care (- 12%), but also tumor surgery (- 9%). Substantial limitations were also reported for all other areas of multidisciplinary oncological care.
CONCLUSIONS
This study documents the limitations of oncological care during the COVID-19 pandemic and highlights the need to develop strategies to avoid similar limitations in the future.
目的
越来越多的国际研究表明，COVID-19 大流行对癌症的及时诊断和癌症治疗产生了严重的负面影响。我们的研究旨在定量和定性评估德国综合癌症中心（CCC）在 COVID-19 大流行的头 2 年中在复杂肿瘤治疗的不同领域的能力。
方法
2020 年 3 月至 2022 年 6 月期间，在德国的 18 个 CCC 中进行了 23 轮前瞻性小组调查。
结果
COVID-19 大流行在头 2 年中极大地影响了德国的肿瘤护理系统。CCC 中护理的持续限制主要影响了随访（-21%）和心理肿瘤护理（-12%），但也影响了肿瘤手术（-9%）。其他所有多学科肿瘤护理领域也报告了重大限制。
结论
本研究记录了 COVID-19 大流行期间肿瘤护理的局限性，并强调需要制定策略以避免未来出现类似的局限性。
Zotero 插件